Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002552:Cerebral Ventricles; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D007267:Injections; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D010848:Picolinic Acids / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013859:Thiocarbamates / Q000494:pharmacology*; D013890:Thiourea / Q000494:pharmacology*
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids; D013859:Thiocarbamates; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D004299:Dopamine beta-Hydroxylase; D013890:Thiourea; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine